$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Is Cycloserine a type of drug that is not recommended to be stopped at will once it is started?
2026-02-01 22:25:32
Check Details
None
2026-02-01 22:25:32
Check Details
Analysis of patients’ real experience feedback and long-term treatment impact after taking ribociclib (Kaillon) for two years
2026-02-01 22:25:32
Check Details
Is Cemiplimab an imported drug and its current status in the domestic supply chain and purchasing channels?
2026-02-01 22:25:32
Check Details
Possible side effects of Daprodustat and key points for long-term safety risk monitoring
2026-02-01 22:25:32
Check Details
Clinical application and efficacy analysis of durvalumab (durvalumab) combined with chemotherapy regimen
2026-02-01 22:25:32
Check Details
Whether Zolbetuximab is available in China and its acquisition channels and approval status
2026-02-01 22:25:32
Check Details
Analysis of whether EIKANCE 0.01% Atropine Sulfate Eye Drops is safe for adults to use and precautions for use
2026-02-01 22:25:32
Check Details
Reasons why methylcobalamin injection (Rozebalamin) is ineffective in treating tinnitus for six days and suggestions for subsequent adjustments
2026-02-01 22:25:32
Check Details
Cobimetinib (cobimetinib) standard usage and dosage guide and dose adjustment for different patients
2026-02-01 22:25:32
Check Details
Latest research progress on the combination of macitentan (Aopuxil) and tadalafil in the treatment of pulmonary arterial hypertension
2026-02-01 22:25:32
Check Details
A summary of real feelings and patient experience sharing after taking Tilorisen (Harcos)
2026-02-01 22:25:32
Check Details
1
2
...
2419
2420
2421
2422
2423
2424
2425
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma